✦ LIBER ✦

Bcl-2 antagonists: a proof of concept for CLL therapy

✍ Scribed by Balakrishnan, Kumudha; Gandhi, Varsha

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A proof-of-concept study: Mirabegron, a

✍ Chapple, Christopher R.; Amarenco, Gerard; López Aramburu, Miguel A.; Everaert, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

Reducing Antimicrobial Therapy for Asymp

✍ Leis, J. A.; Rebick, G. W.; Daneman, N.; Gold, W. L.; Poutanen, S. M.; Lo, P.; L 📂 Article 📅 2014 🏛 University of Chicago Press 🌐 English ⚖ 83 KB

Collapsing Mechanistic Models: An Applic

✍ Matthew M. Hutmacher; Debu Mukherjee; Kenneth G. Kowalski; David C. Jordan 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 331 KB

Therapeutic potential of antisense Bcl-2

✍ Ryungsa Kim; Manabu Emi; Kazuaki Tanabe; Tetsuya Toge 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

ChemInform Abstract: 5-HT2 Antagonists:

✍ D. LEYSEN; J. T. M. LINDERS; H. C. J. OTTENHEIJM 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB 👁 1 views

Oral administration of a tri-therapy for

✍ Pierre A. Guertin; Roth-Visal Ung; Pascal Rouleau 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB